论文部分内容阅读
新新肝康片系我院研制的治疗病毒性肝炎的一种新药，该药的研究系根据病毒性肝炎的发病机理和中医辩证施治的原则。在总结临床经验的基础上，将祖国传统医学和现代医药学理论相结合，科学研制的一种纯中药制剂。该药具有扶正去邪、清热解毒、活血化瘀、强肝益肝等作用。为了给新新肝康片的临床安全性提供可靠的依据，本文考察了新新肝康片对四氯化碳、Ｄ－氨基半乳糖致小鼠急性肝损伤［１］的保护作用及该药物对心、肾、脾脏器的生化指标等项目。
Xinxin Gan Kang film developed in our hospital for the treatment of viral hepatitis, a new drug, the drug’s research based on the pathogenesis of viral hepatitis and dialectical principles of Chinese medicine. On the basis of summing up clinical experiences, a purely traditional Chinese medicine preparation combining scientific research on traditional Chinese medicine and modern medicine is developed. The medicine has Fuzheng to evil, detoxification, promoting blood circulation, strong liver and liver function. In order to provide a reliable basis for the clinical safety of Xinxingankang tablet, this paper examines the protective effect of Xinxingankang tablet on acute liver injury induced by carbon tetrachloride and D-galactosamine in mice [1] and the drug Heart, kidney, spleen biochemical indicators and other projects.